Chang Liu

机构：Novartis (Switzerland), Ministry of Education

发表论文 19 篇 · 总被引 428 次 · h-index 6

代表论文

• Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results (2024 · Nature Medicine · 被引 194)
• Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial (2025 · The Lancet · 被引 128)
• Optimizing CAR T cell therapy for solid tumours: a clinical perspective (2025 · Nature Reviews Clinical Oncology · 被引 29)
• The AKR1C1–CYP1B1–cAMP signaling axis controls tumorigenicity and ferroptosis susceptibility of extrahepatic cholangiocarcinoma (2024 · Cell Death and Differentiation · 被引 21)
• A bispecific antibody–drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trial (2025 · Nature Medicine · 被引 19)
• Phase I study of GUCY2C CAR-T therapy IM96 in patients with metastatic colorectal cancer. (2024 · Journal of Clinical Oncology · 被引 18)